Debby Syahru Romadlon

Debby Syahru Romadlon

Auto-generated profile, based on publicly available information

Debby Syahru Romadlon

Chulalongkorn University, Bangkok, Thailand

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2024 in Diabetes/Metabolism Research and Reviews
Verified
Journal Article
Closed access
DRDebby Syahru Romadlon
Debby Syahru Romadlon
YTYu‐Kang Tu
Yu‐Kang Tu
YCYang‐Ching Chen
Yang‐Ching Chen
FHFaizul Hasan
Faizul Hasan
RKRudy Kurniawan
Rudy Kurniawan
HCHsiao‐Yean Chiu
Hsiao‐Yean Chiu

1 June 2024 in Journal of Nursing Research
Verified
Journal Article
Open access
KCKai-Mei Chang
Kai-Mei Chang
DRDebby Syahru Romadlon
Debby Syahru Romadlon
PCPin-Yuan Chen
Pin-Yuan Chen
FHFaizul Hasan
Faizul Hasan
SGShu-Liu Guo
Shu-Liu Guo
HCHsiao-Yean Chiu
Hsiao-Yean Chiu
Background: Fatigue, a major health concern among patients receiving hemodialysis, is associated with poor quality of life, negative emotions, and cognitive dysfunction. Acupressure is a low-cost and noninvasive traditional Chinese therapy that has been widely used in community and clinic settings. However, the beneficial effects of acupressure on various aspects of fatigue among these patients have not been systematically investigated. Purpose: This study was designed to determine the effects of acupressure on fatigue in patients receiving hemodialysis. The moderating influences of bio-sociodemographic characteristics and methodology on the association between acupressure and posthemodialysis fatigue were also examined. Methods: Four electronic databases were searched for qualified articles published between database inception and November 2, 2022. Only randomized controlled trials designed to investigate the effects of acupressure on fatigue in patients receiving hemodialysis were qualified for consideration. A random-effects model was used for data analysis. Results: Eight randomized controlled trials with 11 effect sizes and 725 participants were included in this study. In these studies, acupressure was found to have a significantly higher alleviation effect on general fatigue (g = −0.78; 95% confidence interval [−1.09, −0.48]) and the behavioral, emotional, sensory, and cognitive domains of fatigue (g = −0.51, −0.51, −0.72, and −0.41, respectively) among patients receiving hemodialysis than those in the control groups. Furthermore, the stimulation of the Shenmen acupoint was found to increase the effects (p < .01) of acupressure on fatigue reduction significantly. Notably, the use of special equipment to perform the acupressure was not found to significantly improve outcomes (p = .99). Conclusions/Implications for Practice: Acupressure is effective in alleviating fatigue in patients receiving hemodialysis, particularly when the Shenmen acupoint is used together with other acupoints, and is effective without the application of special equipment. Acupressure may be adopted as a complementary therapy for fatigue alleviation in patients receiving hemodialysis. Based on the findings, healthcare providers should coach patients receiving hemodialysis with fatigue on how to use acupressure therapy appropriately to alleviate this health concern.

28 November 2022 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DRDebby Syahru Romadlon
Debby Syahru Romadlon
HHHui-Chuan Huang
Hui-Chuan Huang
YCYang-Ching Chen
Yang-Ching Chen
SHSophia H. Hu
Sophia H. Hu
FHFaizul Hasan
Faizul Hasan
HCHsiao-Yean Chiu
Hsiao-Yean Chiu
Patients with type 2 diabetes mellitus (T2DM) often experience fatigue. The Multidimensional Fatigue Inventory (MFI-20) is a valid tool for evaluating fatigue; however, its psychometric properties have not been examined in Indonesian-speaking patients with T2DM. This study assessed the psychometric properties of the Indonesian version of the Multidimensional Fatigue Inventory-20 (IMFI-20) in patients with T2DM and investigated fatigue in a health-care setting. A cross-sectional design was adopted. Two hundred patients with T2DM were interviewed in clinics. Five self-structured measures were used to assess the frequency and duration of fatigue and the health-care utilization of patients with fatigue. Cronbach’s alpha and intraclass correlation (ICC) were used to evaluate the internal consistency and test–retest reliability of the Indonesian version of the MFI-20 (IMFI-20). The criterion, convergent, and known-group validity of the IMFI-20 were also examined, and its underlying structure was determined using explanatory factor analysis. The STROBE checklist was used. The results revealed that approximately half of the patients experienced fatigue. Among those with fatigue, 62% reported that their fatigue was rarely or never treated by their physicians. The IMFI-20 exhibited satisfactory model fit, excellent internal consistency (Cronbach’s alpha of 0.92), and test–retest ICC of 0.93. The IMFI-20 was significantly associated with the Functional Assessment of Chronic Illness Therapy–Fatigue, Beck Depression Inventory-Second Edition, and Pittsburgh Sleep Quality Index (r = 0.705, 0.670, and 0.581, respectively). The IMFI-20 exhibited known-group validity for unfavorable sleep quality and HbA1C ≥ 6.5%. Our findings suggest that patients with T2DM who experience fatigue are often overlooked by health-care providers, and that the IMFI-20, which exhibits excellent psychometric properties, can be adopted by studies that use fatigue as an endpoint in Indonesian-speaking populations.

31 July 2023 in Diabetes, Obesity and Metabolism
Verified
Journal Article
Closed access
DRDebby Syahru Romadlon
Debby Syahru Romadlon
Yu-Kang TuYu-Kang Tu
Yu-Kang Tu
YCYang‐Ching Chen
Yang‐Ching Chen
FHFaizul Hasan
Faizul Hasan
HCHsiao‐Yean Chiu
Hsiao‐Yean Chiu

22 December 2025 in Healthcare
Verified
Journal Article
Open access
PDF file
Emmanuel EkporEmmanuel Ekpor
Emmanuel Ekpor
EAEmefa Awo Adawudu
Emefa Awo Adawudu
SASamuel Adu Agyen
Samuel Adu Agyen
DRDebby Syahru Romadlon
Debby Syahru Romadlon
SASAMUEL AKYIREM
SAMUEL AKYIREM
Background/Objectives: Healthcare discrimination poses significant challenges to the health-related quality of life (HRQoL) of people living with type 2 diabetes (T2D). However, the role of social support in alleviating these effects has not been fully explored. Drawing on Cohen and Wills’ social support buffering model, this study examined whether social support moderates the association between healthcare discrimination and HRQoL among individuals with T2D. Methods: We analyzed data from 5180 adults with T2D enrolled in the All of Us Research Program. Healthcare discrimination was assessed using the modified Everyday Discrimination Scale (mEDS), social support with the Medical Outcomes Study Social Support Survey (MOS-SSS), and HRQoL (physical and mental domains) with the PROMIS Global Health Scale. Moderation analyses were conducted through linear regression models. Results: Greater exposure to healthcare discrimination was associated with poorer physical and mental HRQoL. Social support demonstrated a significant moderating effect on mental HRQoL: as social support increased, the negative association between healthcare discrimination and mental well-being weakened. However, this buffering effect was not observed for physical HRQoL. Conclusions: Findings suggest that social support can mitigate the adverse mental health consequences of healthcare discrimination among individuals with T2D. Interventions aimed at strengthening social support networks warrant investigation as potential strategies to improve the mental HRQoL of people with T2D who encounter discrimination in healthcare environments.

29 January 2025 in Journal of Diabetes Science and Technology
Verified
Journal Article
Closed access
DRDebby Syahru Romadlon
Debby Syahru Romadlon
HHHui-Chuan Huang
Hui-Chuan Huang
YCYu-Chi Chen
Yu-Chi Chen
SHSophia H Hu
Sophia H Hu
RKRudy Kurniawan
Rudy Kurniawan
HCHsiao-Yean Chiu
Hsiao-Yean Chiu
Background: To investigate the effects of personalized DiaBetes TEXT messaging combined with Peer Support Education (DB-TEXT+ PSE) on clinical outcomes in patients with type 2 diabetes. Methods: An assessor-blinded, three-arm randomized controlled trial recruited 84 participants between December 2022 and July 2023. Participants were randomly assigned to a DB-TEXT + PSE group, a DB-TEXT group, or a professional education program (PEP) group. Primary outcomes included glycated hemoglobin (HbA 1c ), fasting blood glucose (FBG) levels, and clinical remission rates, whereas secondary outcomes measured lipid profiles, fatigue, sleep quality, depression, and quality of life (QoL). Outcomes were assessed at baseline (T0), three months (T1), and six months (T2) postintervention. Results: Relative to PEP, personalized DB-TEXT + PSE and DB-TEXT alone led to significantly reduced HbA 1c levels at T1 and decreased FBG levels at T1 and T2. Type 2 diabetes remission was achieved by 35.7% and 50% of the participants in the DB-TEXT + PSE group, by 17.9% and 25% in the DB-TEXT group, and by 3.7% and 3.7% in the PEP group at T1 and T2, respectively. Relative to the PEP, DB-TEXT + PSE led to significantly reduced TC levels, diastolic blood pressure (DBP), and systolic blood pressure (SBP) and improved sleep quality and QoL over time. Conclusions: Personalized DB-TEXT + PSE is more effective at enhancing clinical outcomes, reducing fatigue, improving sleep quality, and improving quality of life in patients with type 2 diabetes than DB-TEXT alone and PEPs are. Educators can incorporate personalized DB-TEXT + PSE as a component of diabetes education programs and thereby integrate digital interventions and supplementary programs.